Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort

References

• Jornell 0, Kanis JA, Oden A, Sembo I, Redlund-Johnell I, Pett-erson C, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15:38–42.
   PubMedGoogle Scholar
• Muraki S, Yamamoto S, Ishibashi H, Nakamura K. Factors associated with mortality following hip fracture in Japan. J Bone Miner Metab. 2006;24:100–4.
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Muraki S, Oka H, Mabuchi A, En-yo Y, Yoshida M, et al. Prevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability (ROAD). J Bone Miner Metab. 2009;27:620–8.
   Google Scholar
• Ministry of Health, Labour and Welfare. The outline of the results of National Livelihood Survey 2007. Available at: http://www.mhlw.go.jp/toukei/list/20-19-1.html Accessed 21st December 2010.
   Google Scholar
• Rosen CJ, Hochberg MC, Bonnick SL, McClung M, Miller P, Broy S, et al. Fosamax Actonel Comparison Trial Investigators. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis. A randomized double-blind study. J Bone Miner Res. 2005;20:141–51.
   Google Scholar
• Rizzoli R, Greenspan SL, Bone G 3rd, Schnitzer TJ, Watts NB, Adami S, et al. Alendronate Once-Weekly Study Group. Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis J Bone Miner Res 2002;17:1988–96.
   Google Scholar
• Shiraki M, Kushida K. Fukunaga M for the Alendronate Phase III Osteoporosis Research Group. A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. Osteoporos Int. 1999;11: 183–92.
   Google Scholar
• Morii H, Ohashi Y, Taketani Y, Fukunaga M, Nakamura T, It-abashi A, et al. Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmeno-pausal women with osteoporosis: results from a randomized placebo-controlled trial. Osteoporos Int. 2003;14:793–800.
   Google Scholar
• Garnero P, Sornay-Rendu E, Duboeuf F, Delmas PD. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res. 1999;4:1614–21.
   Google Scholar
• Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int. 1996;59: 328–33.
   Google Scholar
• Bauer DC, Sklarin PM, Stone KL, Black DM, Nevitt MC, Ensrud KE, et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women. The study of osteoporotic fractures. J Bone Miner Res. 1999;14:1404–10.
   PubMed Web of Science ®Google Scholar
• Iid M, Morita A, Ikeda Y, Sato Y, Akiba T, Matsumoto T, et al. Biochemical markers of bone turnover predict bone loss in per-imenopausal women but not in postmenopausal women-the Japanese Population-Based Osteoporosis (JPOS) cohort study. Osteoporos Int. 1966;17:1086–95.
   Google Scholar
• Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res. 1996;11:1531–8.
   PubMed Web of Science ®Google Scholar
• Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. J Bone Miner Res. 2002;17:826–33.
   Google Scholar
• Garnero P, Sornay-Rendu E, Claustrar B, Delmas PD. Bio-chemical markers of bone turnover, endogenous hormones and the risk of fracture in postmenopausal women: the OFELY study. J Bone Miner Res. 2003;15:1526–36.
   Google Scholar
• Yoshimura N, Hashimoto T, Kasamatsu T, Morioka S, Aoki N, Shiraki M. Bone metabolic marker levels in residents of a rural community in Japan. J Bone Miner Metab. 1996;14:39–42.
   Google Scholar
• Yoshimura N, Hashimoto T, Sakata K, Morioka S, Kasamatsu T, Cooper C. Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck. The Taiji study. Calcif Tissue Int. 1999;65:198–202.
   PubMed Web of Science ®Google Scholar
• Kasamatsu T, Yoshimura N, Morioka S, Sugita K, Hashimoto T. A population survey on bone mineral density in a fishing village in Wakayama Prefecture (Part 1). Distribution of bone mineral density by sex and age on a representative sample of the com-munity. Jpn J Hyg. 1996;50:1084-92. (in Japanese).
   Google Scholar
• Yoshimura N, Kasamatsu T, Morioka S, Hashimoto T. A popu-lation survey on bone mineral density in a fishing village in Wakayama Prefecture (Part 2). The analysis of the risk factors affecting the bone mineral density. Jpn J Hyg. 1996;51:677-84. (in Japanese).
   Google Scholar
• Yoshimura N, Hashimoto T, Morioka S, Sakata K, Kasamatsu T, Cooper C. Determinants of bone loss in a rural Japanese com-munity. The Taiji study. Osteoporos Int. 1998;8:604–10.
   PubMedGoogle Scholar
• Yoshimura N, Kakimoto T, Nishioka M, Kishi T, Iwasaki H, Niwa T, et al. Evaluation of reproducibility of bone mineral density measured by dual energy X-ray absorptiometry (DPX-L). J Wakayama Med Soc. 1997;48:461–6.
   Google Scholar
• World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843. Geneva: WHO; 1994.
   Google Scholar
• Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, et al. Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab. 2001;19: 331–7.
   Google Scholar
• Kawaguchi H, Matsumoto T, Kurokawa T, Orimo H, Mizunashi K, Takuwa Y, et al. Serum levels of BGP determined by two-site immunoradiometric assay (IRMA) using monoclonal antibodies (in Japanese). Clin Endocrinol. 1990;38:95–100.
   Google Scholar
• Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem. 1990;36:1328–32.
   PubMed Web of Science ®Google Scholar
• Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T. Analysis of pyridinoline, a crosslinking compound of collagen fibers, in human urine. J Biochem. 1983;94:1133–6.
   Google Scholar
• Schmidt-Gayk H, Spanuth E, Kotting J, Bard R, FeIsenberg D, Pfeilshifter J, et al. Performance evaluation of automated assays for /3-Crosslaps, N-MID osteocalcin and intact parathyroid hor-mone (BIROSE multicenter study). Clin Chem Lab Med. 2004;42: 90–5.
   Google Scholar
• Gomez B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, et al. Monoclonal antibody assay for measuring bone-spe-cific alkaline phosphatase activity in serum. Clin Chem. 1995;41:1560–6.
   PubMed Web of Science ®Google Scholar
• Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, et al. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem. 1996;42:947–54.
   PubMed Web of Science ®Google Scholar
• Hirota Y, Kurimoto F, Hata K, Miura M. Fundamental studies on the determination of serum intact PINP (amino-terminal pro-peptide of type I procollagen) with RIA method. Clin Endocrinol. 1997;4:431-5. (in Japanese).
   Google Scholar
• Clemens JD, Herrick MV, Singer FR, Eyre DR. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem. 1997;43:2058–63.
   PubMedGoogle Scholar
• Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment. Calcif Tissue Int. 1998;63:102–6.
   Google Scholar
• Yoshimura N, Muraki S, Oka H, Mabuchi A, Kinoshita H, Yoshida M, et al. Epidemiology of lumbar osteoporosis and osteoarthritis and their causal relationship-is osteoarthritis a predictor for osteoporosis, or vice versa?: The Miyama study. Osteoporos Int. 2009;20:999–1008.
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Hashimoto T. Differences of values of BMD between mountainous and fishing areas, Wakayama prefecture, Japan. Osteoporos Jpn. 1999;7:12-3. (in Japanese).
   Google Scholar
• Yoshimura N, Sakata K, Morioka S, Yasuda Y, Hashimoto T, Kasamatsu T. The comparison of incidence of fast bone losers in mountainous and fishing areas. Osteoporos Jpn. 1997;5:231-4. (in Japanese).
   Google Scholar
• Yoshimura N, Hashimoto T, Morioka S, Kasamatsu T, Aoki N, Shiraki M. The difference of distribution of bone metabolic marker levels between mountainous and fishing villages. Osteo-poros Jpn. 1996;4:119-22. (in Japanese).
   Google Scholar
• Wakayama Prefecture. The results of Nutrition Survey in Wa-kayama Prefecture 1993. (in Japanese).
   Google Scholar
• Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Cohort profile: research on osteoarthritis/osteoporosis against disability (ROAD) study. Int J Epidemiol. 2010;39: 988–95.
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Kasamatsu T, Sakata K, Hashimoto T, Cooper C. The relationship between endogenous estrogen, sex hormone binding globulin and bone loss in female residents of a rural Japanese community: the Taiji study. J Bone Miner Metab. 2002;20:303–10.
   Google Scholar
• Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Capacity of endogenous sex steroids to predict bone loss, osteoporosis and osteoporotic fracture in Japanese men: ten-year follow-up of the Taiji cohort study. J Bone Miner Metab 2011;29:96–102.
   PubMedGoogle Scholar
• Yoshimura N, Takijiri T, Kinoshita H, Danjoh S, Kasamatsu T, Morioka S, et al. Characteristics and course of bone mineral densities among fast bone losers in a rural Japanese community: the Miyama study. Osteoporos Int. 2004;15:139–44.
   PubMedGoogle Scholar
• Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J, for the Committee of Scientific Advisors of the International Osteopo-rosis Foundation. The use of biochemical markers of bone turn-over in osteoporosis, Osteoporos Int 11 Suppl 2000;6: 52–17.
   Google Scholar
• Seibel MJ. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos Int. 2000;11(Suppl 6):S18–29.
   PubMedGoogle Scholar